The Scientific Team at Mironid conducts cutting-edge research and development to discover and optimize therapeutic compounds targeting degenerative kidney diseases, chronic inflammatory diseases, and cancer. They collaborate across disciplines, including biology, chemistry, and medicinal chemistry, to advance scientific understanding and drive the progression of drug candidates from concept to clinical trials.
Adele Rowley
Chief Scientific Officer
Dave Adams
Head, Research Chemistry
David Henderson
Head, Biology
Dorien Peters
Scientific Advisor
Enno Klussmann
Scientific Advisor
Jaazba Irfan
Biology research scientist
Julia Adam Phd
Head, Medicinal Chemistry
Peter Charlton
Scientific Advisor
Peter Webborn
Scientific Advisor
Tim Hammond
Scientific Advisor
View all